Upcoming events
28th EADV Congress, 9-13 October 2019 - Madrid, Spain
more information
more information
Upcoming events
News and milestones
July 2021 – Metvix® & MultiLite: In-Label Use for Artificial Daylight PDT
The Metvix® creme of Galderma Laboratorium GmbH has recently received certification for photodynamic therapy (PDT) with artificial daylight. The MultiLite daylight lamp from GME is one of the few artificial daylight systems recommended by Galderma.
Metvix® unfolds its effect under the influence of artificially generated light, which simulates the treatment-relevant spectrum of natural daylight. For more information on Metvix® and the appropriate exposure systems, please see the flyer linked below (German only).
January 2018: GME and Founders purchase shares from Bayern Kapital and BayBG
GME has exercised a pre-agreed purchase option and acquired the GME shares of 2 institutional investors.
The profits generated during the last years enabled the company to „pay-out“ 2 out of 3 institutional investors. GME expects to purchase the shares of the remaining investor (HTGF) in a few years. The long term strategy of GME’s founders is to create a classic German “Mittelstand” company: private, independent and with a long-term perspective.
The transformation from a company financed by venture capital to a „Mittelstand“ company is quite unusual. Thus the transaction has been highlighted in the renowned German “VentureCapital Magazin“ in the edition 04/2018 (German only).
March 2017: Dr. Dieter Manstein has been elected Vice President of ASLMS
Dr. Dieter Manstein, one of the founders of GME, has been elected Vice President of ASLMS!
The American Society for Laser Medicine and Surgery (ASLMS) is the world’s largest professional organization dedicated to promoting research, education and high standards of clinical care in the field of medical laser and energy-based applications.
July 2016: GME receives award from Chamber of Commerce
GME received the Best Start-Up Award (“Gründerpreis”) from the North Bavarian Chamber of Commerce. The award is endowed a prize money of 10,000 Euro. GME is one of the three most successful start-up companies in the region.
Stefan Schulze (GME), Dietmar Fischer (GME), Dirk von Vopelius (President of Chamber of Commerce), Konrad Beugel (Officer for Business of Erlangen)
March 2016: Clear + Brilliant Pélo (LinScan 808) presented at American Academy of Dermatology (AAD)
Valeant International presented the Clear + Brilliant Pélo at the AAD meeting in Washington D.C. a humorous video on laser hair removal was shown on a video wall.
This video also shows a bear that would like to get his hair removed. The bear was very active at Valeant’s booth.
February 2016: Seminar to introduce the LinScan 808 to the Korea market
A market introduction seminar for the LinScan 808 was held in Seoul (Korea) on February 20, 2016. Dr. Dieter Manstein, Dr. Wooseok Koh and Dr. Stefan Schulze explained the principle of linear scanning and showed the excellent clinical results generated in Korea by Dr. Koh.
January 2016: Extension of cooperation with Valeant
The cooperation with Valeant has been extended to selected countries outside North America. Valeant will market LinScan 808 under the name Clear + Brilliant Pélo also in selected countries in Eastern Europe, in Asia as well as in Spain.
December 2015: GME presented as „success story“ by Bayern Kapital
GME’s investor Bayern Kapital celebrated its 20th anniversary in Munich on December 5, 2015. GME was one of the successful companies supported by Bayern Kapital. Ms. Ilse Aigner, Bavarian State Minister of Economic Affairs was very interested in GME‘s products.
November 2015: Successful Inspection by the United States Food and Drug Administration (FDA)
The FDA is inspecting medical device manufacturer exporting to the US from time to time. In November 2015, the GME site in Erlangen and the manufacturing partner Askion were inspected for one week. GME and Askion have successfully passed this inspection – a confirmation for the QM system and the GME products.
September 2015: Excimer Pulsed Light System ExSys308 – approval in Japan
The EPL® Excimer Pulsed Light system ExSys 308 has been approved as a medical device in Japan. The product is marketed in Japan by our partner JMEC.
September 2015: Ground-Breaking partnership with Solta Medical
Solta Medical markets LinScan 808 in the US and Canada as a part of their clear + brilliant line. The name of the product is “pélo™”, the Spanish name for hair. Read more
July 2015: Break-even in H1 2015
Significant revenue growth allowed GME to achieve break-even in H1 2015.
May 2015: CE approval for ExSys 308
The ExSys 308 received the medical CE Certificate issued by TÜV Rheinland on May 8, 2015
December 2014: Dr. Woosok Koh leads round of finance
GME closed a series B round of financing on december 22, 2014. Dr. Wooseok Koh, a renowned laser hair removal expert from Seoul (Korea) joined as a new shareholder.
October 2014: ExSys 308 presented at EADV
The new EPL® (Excimer Pulsed Light) system was presented at the EADV from Oct 8-12, 2014 in Amsterdam.
October 2014: Research grant
GME received notification on October 5, 2014 of a sponsorship by the Bavarian State Ministry of Economy, Infrastructure, Traffic and Technology (BayTP program). The goal of the project is the development of a device for the treatment of oral lichen planus with UVB light.
July 2014: FDA approval for LinScan 808
On July 15, 2014 the LinScan 808 was approved by the FDA for hair removal and permanent hair reduction.
This post is also available in: German
FOLLOW US
